![]() |
|
|
Forward to a colleague |
||
Product Brochure Now you can perform early stage formulation development and clinical experiments starting at 15 gr./batch. Get all critical process parameters in real time and in Excel report. Modular design allows many upgrade possibilities... Click Here Access Full Stories Waters and Thar Instruments have agreed to deepen their collaboration to combine their strengths in mass spectrometry (MS) and super critical fluid chromatography (SFC) to make separation science 'greener'... Read Company Profile: Nikon Instruments LabTechnologist.com brings you an exclusive interview with Robert Forster, General Manager of Nikon UK's Instrument Division... Read EU to fund stem cell assay development collaboration Stem Cell Sciences (SCS) has received a €2.4m boost from the European Union (EU) for its new drug screening development programme using neutral stem cells... Read Plexera and MitoSciences to develop ADME/Tox arrays Plexera and MitoSciences will collaborate to commercialise an antibody array designed to study mitochondrial function that could become an integral part of ADME/Tox (absorption, distribution, metabolism, excretion... Read Product news in brief - week 39 LabTechnologist.com brings you a round up of product news and new releases from Bio-Rad, FEI, Harvard Apparatus, Horiba Instruments, Malvern Instruments, Thermo Fisher Scientific and Warner Instruments... Read |
||||||||||||||
All News Headlines for: September | August | July |
||||||||||||||
|
DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here |
||||||||||||||
|
Related Industry News SAFC in latest biomanufacturing capacity expansion Contract manufacturer SAFC is investing $29m (€21m) to expand its Jerusalem, Israel manufacturing capacity for high-potency biologics... Read AZ hoping its prostate cancer drug will succeed where Abbott's failed After decades of limited options and false hopes, prostate cancer sufferers will be hoping AstraZeneca's (AZ) new drug can succeed where Abbott's failed... Read AstraZeneca teams up to fight Japan's drug lag AstraZeneca has teamed up with a Japanese university to co-conduct clinical trials in an effort to tackle Japan's so-called 'drug lag'... Read GSK jumps on the 'reverse genetics' bandwagon GlaxoSmithKline (GSK) has licensed MedImmune's 'reverse genetics' technology for use in its non-live human influenza vaccines production programme... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||